1 Start 2 Complete Learner Demographics * Physician Nurse Other Overall Series Rating * ExcellentSatisfactoryPoor ExcellentSatisfactoryPoor Overall, how would you rate this series? Overall, how would you rate this series? - Excellent Overall, how would you rate this series? - Satisfactory Overall, how would you rate this series? - Poor Extent to which identified Series objectives were met: I am better able to ... * OutstandingGoodSatisfactoryFairPoor OutstandingGoodSatisfactoryFairPoor Discuss treatment planning for neuroendocrine tumors (NETs). Discuss treatment planning for neuroendocrine tumors (NETs). - Outstanding Discuss treatment planning for neuroendocrine tumors (NETs). - Good Discuss treatment planning for neuroendocrine tumors (NETs). - Satisfactory Discuss treatment planning for neuroendocrine tumors (NETs). - Fair Discuss treatment planning for neuroendocrine tumors (NETs). - Poor Identify cutting edge therapies (interventional radiology techniques, new surgical approaches and new systemic therapies) for patients with NET. Identify cutting edge therapies (interventional radiology techniques, new surgical approaches and new systemic therapies) for patients with NET. - Outstanding Identify cutting edge therapies (interventional radiology techniques, new surgical approaches and new systemic therapies) for patients with NET. - Good Identify cutting edge therapies (interventional radiology techniques, new surgical approaches and new systemic therapies) for patients with NET. - Satisfactory Identify cutting edge therapies (interventional radiology techniques, new surgical approaches and new systemic therapies) for patients with NET. - Fair Identify cutting edge therapies (interventional radiology techniques, new surgical approaches and new systemic therapies) for patients with NET. - Poor Assess the best sequencing opportunities. Assess the best sequencing opportunities. - Outstanding Assess the best sequencing opportunities. - Good Assess the best sequencing opportunities. - Satisfactory Assess the best sequencing opportunities. - Fair Assess the best sequencing opportunities. - Poor Discuss NET clinical trials. Discuss NET clinical trials. - Outstanding Discuss NET clinical trials. - Good Discuss NET clinical trials. - Satisfactory Discuss NET clinical trials. - Fair Discuss NET clinical trials. - Poor Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Outstanding Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Good Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Satisfactory Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Fair Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics). - Poor Do you believe the subject matter presented/discussed was: * YesNo YesNo Objective Objective - Yes Objective - No Fair & Balanced Fair & Balanced - Yes Fair & Balanced - No Free of Commercial Bias Free of Commercial Bias - Yes Free of Commercial Bias - No Have you made changes to your practice as a result of this series? Yes No Please describe: Do you have any recommendations for the moderator(s)/facilitator(s) of this series? Yes No Please describe: The Series included educational components that addressed cultural linguistic competency and implicit bias Yes No N/A (If a research or non-direct patient care series) Outside of this activity, what additional topics would you like addressed in other educational opportunities? Leave this field blank
